Bibliography - Gynecologic - ThinPrep® Pap Test

Note: Information contained in articles described below may refer to the ThinPrep® 2000 System or to a predecessor processor and system which uses similar technology but was not approved by the U.S. Food and Drug Administration ("FDA") for gynecological applications. The ThinPrep 2000 System was approved by the FDA for gynecological applications in May 1996.

Direct-to-vial Studies
Ashfaq R, Gibbons D, Vela C, Saboorian MH, Iliya F: ThinPrep Pap Test accuracy for glandular disease. Acta Cytol 1999;43:81-85.

Bai H, Sung CJ, Steinhoff MM: ThinPrep Pap Test promotes detection of glandular lesions of the endocervix. Diagn Cytopathol 2000; 23:19-22.

Baker JJ: Conventional and liquid-based cervicovaginal cytology: A comparison study with clinical and histologic follow-up. Diagn Cytopathol 2002;27(3):185-88.

Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, Pan QJ, Fischer C, Lorincz A, Zahniser D: Shanxi Province cervical cancer screening study: A cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-44.

Belinson J, Qiao Y, Pretorius R, Zhang W, Keaton K, Elson P, Fischer C, Lorincz A, Zahniser D, Wilbur D, Pan Q, Li L, Biscotti C, Dawson A, Li A, Wu L, Ling Y, Ma CP, Yang YP: Prevalence of cervical cancer and feasibility of screening in rural China: A pilot study for the Shanxi Province Cervical Cancer Screening Study. Int J Gynecol Cancer 1999;9:411-7.

Bolick DR, Hellman DJ: Laboratory implementation and efficacy assessment of ThinPrep cervical cancer screening system. Acta Cytol 1998;42:209-213.

Carpenter AB, Davey DD: ThinPrep Pap Test: performance and biopsy follow-up in a university hospital. Cancer (Cancer Cytopathol) 1999;87(3):105-12.

Cheung AN, Szeto EF, Leung BSY, Khoo US, Ng AWY: Liquid-based cytology and conventional cervical smears: A comparison study in an Asian screening population. Cancer (Cancer Cytopathol) 2003;99(6):331-5.

Corkill M, Knapp D, Martin J, Hutchinson ML: Specimen adequacy of ThinPrep sample preparations in a direct-to-vial study. Acta Cytol 1997;41:39-44.

Diaz-Rosario LA, Kabawat SE: Performance of a fluid-based, thin-layer Papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. Arch Pathol Lab Med 1999;123(9):817-21.

Duggan MA, Khalil M, Brasher PMA, Nation JG: Comparative study of the ThinPrep Pap Test and conventional cytology results in a Canadian cohort. Cytopathology 2006;17(2):73-81.

Dupree WB, Suprun HZ, Beckwith DG, Shane JJ, Lucente V: The promise and risk of a new technology: The Lehigh Valley Hospital's experience with liquid-based cervical cytology. Cancer (Cancer Cytopathol) 1998;84:202-207.

Ferris DG, Heidemann NL, Litaker MS, Crosby JH, Macfee MS: The efficacy of liquid-based cervical cytology using direct-to-vial sample collection. J Fam Pract 2000;49(11):1005-11.

Guidos BJ, Selvaggi SM: Use of the ThinPrep Pap Test in clinical practice. Diagn Cytopathol 1999;20:70-73.

Guo M, Hu L, Martin L, Liu S, Baliga M, Hughson M.: Accuracy of Liquid Based Pap Tests: Comparison of Concurrent Liquid-Based Tests and Cervical Biopsies on 782 Women with Previously Abnormal Pap Smears. Acta Cytol 2005;49(2):132-8.

Hatch K, Sheets E, Kennedy A, Ferris D, Darragh T, Twiggs L: Multicenter Direct to Vial Evaluation of a Liquid-Based Pap Test. J Low Genit Tract Dis 2004;8(4):308-12.

Henderson S, Stevens M, Walker T. Rapid review of liquid-based smears as a quality control measure. Diagn Cytopathol 2004;31(3):141-6.

Hoelund B: Implementation of liquid-based cytology in the screening programme against cervical cancer in the County of Funen, Denmark and status for the first year. Cytopathology 2003;14(5):269-74.

Johnson JE, Rahemtulla A: Endocervical glandular neoplasia and its mimics in ThinPrep Pap tests. A descriptive study. Acta Cytol 1999;43(3):369-75.

Limaye A, Connor AJ, Huang X, Luff R: Comparative analysis of conventional Papanicolaou tests and a fluid-based thin-layer method. Arch Pathol Lab Med 2003;127(2):200-4.

Nam JH, Kim HS, Lee JS, Choi HS, Min KW, Park CS. A comparison of modified MonoPrep2 of liquid-based cytology with ThinPrep Pap test. Gynecol Oncol 2004;94(3):693-8.

Negri G, Menia E, Egarter-Vigl E, Vittadello F, Mian C. ThinPrep versus conventional Papanicolaou smear in the cytologic follow-up with women with equivocal cervical smears. Cancer 2003; 99(6):342-5.

Obwegeser JH, Brack S: Does liquid-based technology really improve detection of cervical neoplasia? A prospective, randomized trial comparing the ThinPrep Pap Test with the conventional Pap test, including follow-up of HSIL cases. Acta Cytol 2001;45:709-14.

Papillo J, Zarka MA, St. John TL: Evaluation of the ThinPrep Pap Test in clinical practice: a seven-month 16,314-case experience in northern Vermont. Acta Cytol 1998;42:204-208.

Schledermann D, Ejersbo D, Hoelund B. Significance of atypia in conventional Papanicolaou smears and liquid-based cytology: a follow-up study. Cytopathology 2004;15(3):148-53.

Schorge JO, Saboorian MH, Hynan L, Ashfaq R: ThinPrep detection of cervical and endometrial adenocarcinoma: A retrospective cohort study. Cancer (Cancer Cytopathol) 2002;96(6):338-43.

Selvaggi SM: Cytologic features of high-grade squamous intraepithelial lesions involving endocervical glands on ThinPrep cytology. Diagn Cytopathol 2002;26(3):181-85.

Selvaggi SM, Guidos BJ: Endocervical component: Is it a determinant of specimen adequacy? Diagn Cytopathol 2002;26(1):53-55.

Selvaggi SM, Guidos BJ: Specimen adequacy and the ThinPrep Pap Test: The endocervical component. Diagn Cytopathol 2000;23(1):23-26.

Taylor S, Kuhn L, Dupree W, Denny L, De Souza M, Wright TC Jr: Direct comparison of liquid-based and conventional cytology in a South African screening trial. Int J Cancer 2005;118(4):957-62.

Weintraub J, Morabia A: Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer. Diagn Cytopathol 2000;22(1):52-9.

Williams ARW: Liquid-based cytology and conventional smears compared over two 12-month periods. Cytopathology 2006;17(2):82-5.

Yeoh GPS, Chan KW, Lauder I, Lam MB: Evaluation of the ThinPrep Papanicolaou Test in clinical practice: Six-month study of 16, 541 cases with histological correlation in 220 cases. Hong Kong Med J 1999;5:233-9.

Split-Sample Studies
Biscotti CV, O'Brien DL, Gero MA, Gramlich TL, Kennedy AW, Easley KA: Thin-layer Pap test vs. conventional Pap smear: Analysis of 400 split samples. J Reprod Med 2002;47(1):9-13.

Chhieng DC, Talley LI, Roberson J, Gatscha RM, Jhala NC, Elgert PA: Interobserver variability: Comparison between liquid-based and conventional preparations in gynecologic oncology. Cancer (Cancer Cytopathol) 2002;96(2):67-73.

Clark SB, Dawson AE: Invasive squamous-cell carcinoma in ThinPrep specimens: Diagnostic clues in the cellular pattern. Diagn Cytopathol 2002;26(1):1-4.

Corkill M, Knapp D, Hutchinson ML: Improved accuracy for cervical cytology with the ThinPrep method and the endocervical brush-spatula collection procedure. J Lower Gen Tract Dis 1998;2:12-16.

Cremer M, de LasCasas L, Kurtycz DFI, Schink J.: Liquid-based cytology specimen studies to screen for cervical dysplasia in rural El Salvador. Int J Gynecol & Obstet 2005;90(2):167-70.

Ferreccio C, Bratti M, Sherman M, Herrero R, Wacholder S, Hildesheim A, Burk RD, Hutchinson M, Alfaro M, Greenberg M, Morales J, Rodriguez A, Schussler J, Eklund C, Marshall G, Schiffman M: A comparison of single and combined visual, cytologic, and virologic tests as screening stratedies in a region at high risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 2003;12:815-23.

Grace A, McBrearty P, Troost S, Thornhill M, Kay E, Leader M: Comparative study: Conventional cervical and ThinPrep Pap Tests in a routine clinical setting. Cytopathology 2002;13:200-05.

Harkness CB, Theofrastous JP, Ibrahim SN, Galvin SL, Lawrence HC: Papanicolaou and thin-layer cervical cytology with colposcopic biopsy control: A comparison. J Reprod Med 2003;48(9):681-6.

Haroon S, Samayoa L, Witzke D, Davey D: Reproducibility of cervicovaginal ThinPrep cellularity assessment. Diagn Cytopathol 2002;26(1):19-21.

Hussein T, Desai M, Tomlinson A, Kitchener HC: The comparative diagnostic accuracy of conventional and liquid-based cytology in a colposcopic setting. BJOG 2005;112(11):1542-6.

Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, Hildesheim A, Lorincz AT, Greenberg MD, Morales J, Schiffman M: Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer (Cancer Cytopathol) 1999;87(2):48-55.

Inhorn SL, Wilbur D, Zahniser D, Linder J: Validation of the ThinPrep Pap Test for cervical cancer diagnosis. J Low Gen Tract Dis 1998;2:208-212.

Lee KR, Darragh TM, Joste NE, Krane JF, Sherman ME, Hurley LB, Allred EM, Manos MM: Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparations. Am J Clin Pathol 2002;117:96-102.

Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inhorn SL: Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 1997;90:278-284.

Linder J, Zahniser DJ: ThinPrep Papanicolaou testing to reduce false-negative cervical cytology. Arch Path Lab Med 1998;122:139-144.

Luthra UK, Chishti M, Dey P, Jolly SV, Abdulla M, Das DK, Sugathan TN, Ajrawi MT, George J, George SS, Aziz AA, Al-Juwaiser A, Karim FA, Mallik MK, Sheikh ZA, Khan S: Performance of monolayered cervical smears in a gynecology outpatient setting in Kuwait. Acta Cytol 2002; 46(2):303-10.

Malle D, Pateinakis P, Chakka E, Destouni C: Experience with a thin-layer, liquid-based cervical cytologic screening method. Acta Cytol 2003;47(2):129-134.

Menezes GA, Wakely PE, Stripe DM, Nuovo GJ: Increased incidence of atypical Papanicolaou tests from ThinPreps of postmenopausal women receiving hormone replacement therapy. Cancer (Cancer Cytopathol) 2001;93(6):357-63.

Monsonego J, Autillo-Touati A, Bergeron C, Dachez R, Liaras J, Saurel J, Zerat L, Chatelain P, Mottot C: Liquid-based cytology for primary cervical cancer screening: A multi-centre study. Br J Cancer 2001 Feb 2;84(3):360-6.

Park IA, Lee SN, Chae SW, Park KH, Kim JW, Lee HP: Comparing the accuracy of ThinPrep Pap tests and conventional Papanicolaou smears on the basis of the histologic diagnosis: A clinical study of women with cervical abnormalities. Acta Cytol 2001;45(4):525-31.

Rinas AC, Mittman BW, Van Le L, Hartmann K, Cayless J, Singh HK: Split-Sample Analysis of Discarded Cells from Liquid-Based Pap Smear Sampling Devices. Acta Cytol 2006;50(1)55-62.

Ring M, Bolger N, O'Donnell M, Malkin A, Bermingham N, Akpan E, Mulcahy F, Turner NJ, Griffin M, O'Leary JJ: Evaluation of liquid-based cytology in cervical screening of high-risk populations: A split study of colposcopy and genito-urinary medicine populations. Cytopathology 2002;13:152-59.

Roberts JM, Thurloe JK, Bowditch RC, Humcevic J, Laverty CR: Comparison of ThinPrep and Pap smear in relation to prediction of adenocarcinoma in situ. Acta Cytol 1999; 43(1):74-80.

Roberts JM, Gurley AM, Thurloe JK, Bowditch R, Laverty CR: Evaluation of the ThinPrep Pap Test as an adjunct to the conventional Pap smear. Med J Aust 1997;167:466-467.

Rooney CM, Hopkins MP, Oza R, Nelson K, Alford W: The Efficacy of the ThinPrep Pap preparation versus conventional means of cervical cancer screening. J Pelvic Med Surg 2004;10(1):31-5.

Sherman ME, Mendoza M, Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inhorn SL, Zahniser DJ, Baber G, Barber C, Stoler MH: Performance of liquid-based, thin-layer cervical cytology: Correlation with reference diagnoses and human papillomavirus testing. Mod Pathol 1998;11:837-843.

Sherman ME, Schiffman MH, Lorincz AT, Herrero R, Hutchinson ML, Bratti C, Zahniser D, Morales J, Hildesheim A, Helgesen K, Kelly D, Alfaro M, Mena F, Balmaceda I, Mango L, Greenberg M: Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer 1997;81:89-97.

Shield PW, Nolan GR, Phillips GE, Cummings MC: Improving cervical cytology screening in a remote, high risk population. Med J Aust 1999;170(6):255-8.

Song LH, Goh EST, Phang LC, Poh WT, Tay SK: Technical Aspect of ThinPrep. Singapore Med J 2000;41(12):575-8.

Tuncer ZS, Basaran M, Sezgin Y, Firat P, Mocan Kuzey G: Clinical results of a split sample liquid-based cytology (ThinPrep) study of 4,322 patients in a Turkish institution. Eur J Gynaecol Oncol 2005;26(6):646-8.

Wang TY, Chen HS, Yang YC, Tsou MC: Comparison of fluid-based, thin-layer processing and conventional Papanicolaou methods for uterine cervical cytology. J Formos Med Assoc 1999;98(7):500-5.

Meta-Analyses
Abulafia O, Pezzullo JC, Sherer DM: Performance of the ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: A quantitative survey. Gynecol Oncol 2003;90(1):137-144.

Bernstein SJ. Sanchez-Ramos, L, Ndubisi B: Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: A metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 2001;185:308-17.

Davey E, Barratt A, Irwig L, Chan SF, Macaskill P, Mannes P, Saville AM: Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 2006; 367:122-32.

Klinkhamer P, Meerding W, Rosier P, Hanselaar A: Liquid-based cervical cytology: A review of the literature with methods of evidence-based medicine. Cancer (Cancer Cytopathol) 2003;99(5):263-71.

Case Reports
Ciesla MC, Guidos BJ, Selvaggi SM: Cytomorphology of small-cell (neuroendocrine) carcinoma on ThinPrep(R) cytology as compared to conventional smears. Diagn Cytopathol 2001;24(1):46-52.

Hoerl HD et al: Exfoliative cytology of primary poorly differentiated (small-cell) neuroendocrine carcinoma of the uterine cervix in ThinPrep material. A case report. Diagn Cytopathol 2000; 23(1):14-18.

Review Articles
Andy C, Turner LF, Neher JO. Is the ThinPrep better than conventional Pap smear at detecting cervical cancer? J Fam Pract 2004;53(4):313-5.

Austin RM, Ramzy I: Increased detection of epithelial cell abnormalities by liquid-based gynecologic cytology preparations. A review of accumulated data. Acta Cytol 1998;42(1):178-84.

Broadstock M: Liquid-based cytology: An alternative international view. Cytopathology 2001;12:141-3.

Doyle B, O'Farrell C, Mahoney E, Turner L, Magee D, Gibbons D: Liquid-based cytology improves productivity in cervical cytology screening. Cytopathology 2006;17(2):60-4.

Farnsworth A: Liquid-based cytology: An Australian experience. Cytopathology 2003;14:48-52.

Hartman KE, Nanda K, Hall S, Myers E: Technologic advances for evaluation of cervical cytology: Is newer better? Obstet Gynecol Surv 2001;56(12):765-774.

Kurtycz D, Hoerl H: Thinlayer technology: Tempered enthusiasm. Diagn Cytopathol 2000;23(1):1-5.

Linder J: Recent advances in thin-layer technology. Diagn Cytopathol 1998;18(1):24-32.

Linder J, Zahniser D. The ThinPrep Pap Test: A review of clinical studies. Acta Cytol 1997;41(1):30-38.

Myers ER: Improving the sensitivity of cervical cytology: What are the issues? Am J Manag Care 2000; 6:838-40.

Nanda K et al: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-819.

Obwegeser J, Schneider V: Thin-layer cervical cytology: a new meta-analysis. Lancet 2006;367:88-9.

Perlman SE: Pap smears: Screening, interpretation, treatment. Adolesc Med 1999;10(2):243-54.

Rappaport KM, Forrest CB, Holtzman NA. Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists. Health Serv Res 2004;39(4 Pt 1):927-47.

Renshaw AA, Dubray-Benstein B, Cobb CJ, Loano RL, Neal MH, Prey M, Schulty MA; Gynecologic Cytology Committee, College of American Pathologists: Cytologic features of squamous cell carcinoma in ThinPrep slides: evaluation of cases that performed poorly versus those that performed well in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2004; 128(4):403-5.

Renshaw AA, Young NA, Birdsong GG, Styer PE, Davey DD, Mody DR, Colgan TJ: Comparison of performance of conventional and ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program. Arch Pathol Lab Med 2004; 128(1): 17-22.

Renshaw AA, Schulte MA, Plott E, Dubray-Benstein B, Cobb CJ, Lozano RL, Neal MH, Hughes JH, Young NA, Prey M. Cytologic features of high-grade squamous intraepithelial lesion in ThinPrep Papanicolaou test slides: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2004;128(7):746-8.

Soler ME, Blumenthal PD: New technologies in cervical cancer screening. Curr Opin Oncol 2000;12:460-465.

Spitzer M: Cervical screening adjuncts: Recent advances. Am J Obstet Gynecol 1998;179(2):544-56.

Stoler MH: Advances in cervical screening technology. Mod Pathol 2000;12(3):275-84.

Wilson PO: Liquid-based cytology: the evidence is out there? Cytopathology 2006;17(2):57-9.

Adjunctive Testing - Molecular & HPV Testing
Akpolat I, Smith DA, Ramzy I, Chirala M, Mody DR. The utility of p16INK4a and Ki-67 staining on cell blocks prepared from residual thin-layer cervicovaginal material. Cancer. 2004;102(3):142-9.

Al-Awadhi R, Van Noorden S, Coleman DV. Evaluation of NMP179 for the detection of squamous intraepithelial neoplasia in ThinPrep cervical slides using a combination of double immunostaining and morphometric methods of analysis. Diagn Cytopathol 2004;31(3):135-40.

Bergeron C, Cas F, Fagnani F, Didailler-Lambert F, Poveda JD: Human Papillomavirus Testing with a Liquid-Based System: Feasibility and Comparison with Refrence Diagnoses. Acta Cytol 2006;50(1):16-21.

Bianchi A, Moret F, Desrues JM, Champenois T, Dervaux Y, Desvouas O, Oursin A, Quinzat D, Dachez R, Bathelier C, Ronsin C: PreservCyt transport medium used for the ThinPrep Pap test is a suitable medium for detection of Chlamydia trachomatis by the COBAS Amplicor CT/NG test: Results of a preliminary study and future implications. J Clin Microbiol 2002;40(5):1749-54.

Bibbo M, DeCecco J, Kovatich AJ: P16INK4a as an adjunct test in liquid-based cytology. Anal Quant Cytol Histol 2003;25(1):8-11.

Bibbo M, Klump WJ, DeCecco J, Kovatich AJ: Procedure of immunocytochemical detection of P16INK4a antigen in thin-layer, liquid-based specimens. Acta Cytol 2002;46(1):25-29.

Bollman M, Varani AD, Griefingholt H, Bankfalvi A, Callenberg H, Speigh N, Schmitt C, Bollman R: Predicting treatment outcome in cervical diseases using liquid-based cytology, dynamic HPV genotyping and DNA cytometry. Anticancer Res 2006;26(2B):1439-46.

Bollmann R, Mehes G, Torka R, Speich N, Schmitt C, Bollmann M: Determination of features indicating progression in atypical squamous cells with undetermined significance: Human papillomavirus typing and DNA ploidy analysis from liquid-based cytologic samples. Cancer (Cancer Cytopathol) 2003;99(2):113-7.

Bollmann R, Mehes G, Torka R, Speich N, Schmitt C, Bollmann M: Human papillomavirus typing and DNA ploidy determination of squamous intraepithelial lesions in liquid-based cytologic samples. Cancer (Cancer Cytopathol) 2003;99(1):57-62.

Carozzi FM, Del Mistro A, Confortini M, Sani C, Puliti D, Trevisan R, De Marco L, Tos AG, Girlando S, Palma PD, Pellegrini A, Schiboni ML, Crucitti P, Pierotti P, Vignato A, Ronco G: Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting. Am J Clin Pathol 2005;124(5):716-21.

Castle PE, Solomon D, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Rodriquez AC, Alfaro M, Hutchinson ML, Dunn ST, Kuypers J, Schiffman M: Stability of archived liquid-based cervical cytological specimens. Cancer (Cancer Cytopathol) 2003;99(2):89-96.

Cheung AN, Chiu PM, Tsun KL, Khoo US, Leung BS, Ngan HY. Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology. J Clin Pathol 2004;57(7):721-7.

Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, Nazeyrollas P, Gabriel R, Quereux C, Birembault P: Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: A study of 7,932 women. Br J Cancer 2001;89(12):161-23.

Crum CP, Genest DR, Krane JF, Hogan C, Sun D, Bellerose B, Kostopoulou E, Lee KR: Subclassifying atypical squamous cells in ThinPrep cervical cytology correlates with detection of high-risk human papillomavirus DNA. Am J Clin Pathol 1999;112:384-90.

Cubie HA, Moore C, Waller M, Moss S; National Cervical Screening Committee LBC/HPV Pilot Steering Group: The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies. J Clin Virol 2005;33(4):287-92.

Cubie HA, Seagar AL, McGoogan E, Whitehead J, Brass A, Arends MJ, Whitley MW: Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18. J Clin Pathol 2001;54:24-9.

Dallenbach-Hellweg G, Trunk MJ, von Knebel Doeberitz M. Traditional and new molecular methods for early detection of cervical cancer. Arch Pathol Lab Med 2004;66(5):35-9.

Dimulescu I, Unger ER, Lee DR, Reeves WC, Vernon SD: Characterization of RNA in Cytologic Samples Preserved in a Methanol-Based Collection Solution. Mol Diagn 1998;3(2):67-71.

Eltoum IA, Chhieng DC, Roberson J, McMillon D, Partridge EE: Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women. Cancer (Cancer Cytopathol) 2005; 105(4):194-8.

Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K: Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006;106((5):1054-64.

Feng J, Husain M: Reflex high-risk human papillomavirus DNA testing (Hybrid Capture 2) of bloody ThinPrep specimens with atypical squamous cells of undetermined significance interpretation. Cancer (Cancer Cytopathol) 2005;105(5):452-6.

Ferenczy A, Franco E, Arseneau J, Wright TC, Richart RM: Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am J Obstet Gynecol 1996;175(3 Pt.1):651-6.

Ferris DG, Schiffman M, Litaker MS, for the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) group: Cervicography for triage of women with mildly abnormal cervical cytology results. Am J Obstet Gynecol 2001;185(4):939-43.

Fiel-Gan MD, Villamil CF, Mandavilli SR, Ludwig ME, Tsongalis GJ: Rapid detection of HSV from cytologic specimens collected into ThinPrep fixative. Acta Cytol 1999;43:1034-1038.

Ghanem KG, Koumans EH, Johnson RE, Sawyer MK, Papp JR, Unger ER, Black CM, Markowitz LE: Effect of Specimen Order on Chlamydia trachomatis and Neisseria gonorrhoeae Test Performance and Adequacy of Papanicolaou Smear. J Pediatr Adolesc Gynecol 2006;19(1):23-30.

Hildebrandt EF, Lee JR, Crosby JH, Ferris DG, Anderson MG: Liquid-based Pap smears as a source of RNA for gene expression analysis. Appl Immunohistochem Mol Morphol 2003;11(4):345-51.

Hong IS, Marshalleck J, Williams RH, Gaiter TE, Mielzynska-Lohnas I, Kim K: Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. Acta Cytol 2002;46(5):828-34.

Hopwood J, Mallinson H, Hodgson E, Hull L. Liquid based cytology: examination of its potential in a chlamydia screening programme. Sex Transm Infect 2004;80(5):371-3.

Hughes SA, Sun D, Gibson C, Bellerose B, Rushing L, Chen H, Harlow BL, Genest DR, Sheets ER, Crum CR: Managing atypical squamous cells of undetermined significance (ASCUS): Human papillomavirus testing, ASCUS subtyping, or follow-up cytology? Am J Obstet Gynecol 2002;186(3):396-403.

Inhorn SL, Wand PJ, Wright TC, Hatch KD, Hallum J, Lentrichia BB: Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study. J Reprod Med 2001;46(3):237-42.

Keegan H, Boland C, Malkin A, Griffin M, Ryan F, Lambkin H: Comparison of DNA extraction from cervical cells collected in PreservCyt solution for the amplification of Chlamydia trachomatis. Cytopathology 2005;16(2): 82-7.

Kim JJ, Wright TC, Goldie SJ: Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002; 287(18):2382-90.

Koumans EH, Black CM, Markowitz LA, Unger ER, Pierce A. Sawyer MK, Papp JR: Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid Pap smear medium. J Clin Microbiol 2003;41(4):1507-11.

Lara-Torre E, Pinkerton JS: Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolaou smear. Am J Obstet Gynecol 2003;188:354-6.

Lee GY, Kim SM, Rim SY, Choi HS, Park CS, Nam JH. Human papillomavirus (HPV) genotyping by HPV DNA chip in cervical cancer and precancerous lesions. Int J Gynecol Cancer 2005;15(1):81-7.

Liman AK, Giampoli EJ, Bonfiglio TA: Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing? Cancer (Cancer Cytopathol) 2005;105(6):457-60.

Lin WM, Ashfaq R, Michalopulos EA, Maitra A, Gazdar AF, Muller CY: Molecular Papanicolaou tests in the twenty-first century: Molecular analyses with fluid-based Papanicolaou technology. Am J Obstet Gynecol 2000;183:39-45.

Lu DW, Pirog EC, Zhu X, Wang HL, Pinto KR: Prevalence and typing HPV DNA in atypical squamous cells in pregnant women. Acta Cytol 2003;47(6):1008-16.

Maksem JA, Bedrossian CW, Kurtycz D, Sewall S, Shalkham J, Dhanwada V, Lind H, Bibbo M, Weidmann J, Kane B, Shi Fu Y: Resolving ASCUS without recourse to HPV testing: Manual reprocessing of residual automated liquid-based cytology (ALBC) material using manual liquid-based cytology (MLBC). Diagn Cytopathol 2005;33(6):434-40.

Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang Y, Gold K, Barter J, Shah K: Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002;287(18):2372-81.

Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA: Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610.

Menezes G, Euscher E, Schwartz B, Catania F, Chancellor J, Nuovo GJ: Utility of the in situ detection of HPV in Pap smears diagnosed as within normal limits. Acta Cytol 2001;45(6):919-26.

Moore GD, Lear SC, Wills-Frank LA, Martin AW, Snyder JW, Helm CW. Differential expression of cdk inhibitors p16, p21cip1, p27kip1, and cyclin E in cervical cytological smears prepared by the ThinPrep method. Diagn Cytopathol 2005;32(2):82-7.

Murphy N, Ring M, Heffron CC, King B, Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O, O'Leary JJ: p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005;58(5):525-34.

Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ: P16INK4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003;56(1):56-63.

Negri G, Rigo B, Vittadello F, Egarter-Vigl E, Mian C. Human papillomavirus typing with hybrid capture II on archived liquid-based cytologic specimens: is HPV typing always reproducible? Am J Clin Pathol 2004;122(1):90-3.

Negri G. Gampenrieder J, Vig; EE, Haitel A, Menia E, Mian C: Human Papilloma virus typing at large loop excision of the transformation zone of the cervice uteri. Anticancer Res 2003;23(5b): 4289-92.

Negri G, Egarter-Vigl E, Kasal A, Romano F, Haitel A, Mian C: P16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. Am J Surg Pathol 2003;27(2):187-193.

Pan Q, Belinson JL, Li L, Pretorius RG, Qiao YL, Zhang WH, Zhang X, Wu LY, Rong SD, Sun YT: A thin-layer, liquid-based Pap test for mass screening in an area of China with a high incidence of cervical carcinoma: A cross-sectional, comparative study. Acta Cytol 2003;47(1):45-50.

Pantanowitz L, Florence RR, Goulart RA, Otis CN : Trichomonas vaginalis P16 immunoreactivity in cervicovaginal Pap tests: a diagnostic pitfall. Diagn Cytopathol 2005;33(3):210-3.

Peyton CL, Schiffman M, Lorincz AT, Hunt WC, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera LA, Rodriguez AC, Herrero R, Sherman ME, Wheeler CM: Comparison of PCR and Hybrid Capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 1998;36(11):3248-54.

Pinto KR, Lu DW, Rader JS, Davila RM: Double cervix with bilateral and synchronous HSIL associated with different high-risk HPV types. A case report. Acta Cytol 2004;48(2):273-7.

Pirog EC, Erroll M, Harigopal M, Centeno BA: Comparison of human papillomavirus DNA prevalence in atypical squamous cells of undetermined significance subcategories as defined by the original Bethesda 1991 and the new Bethesda 2001 Systems. Arch Pathol Lab Med 2004;128(5):527-32.

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH: Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia. Zhonghua Fu Chan Ke Za Zhi 2006;41(1):34-7. [article in Chinese]

Quddus MR, Zhang S, Sung CJ, Liu F, Neves T, Struminsky J, Singer DB: Utility of HPV DNA detection in thin-layer, liquid-based tests with atypical squamous metaplasia. Acta Cytol 2002;46(5):808-12.

Qureshi MN, Bolick D, Ringer PJ, Spagler FL, Zimmerman G: HPV testing in liquid cytology specimens: comparison of analytic sensitivity and specificity for in situ hybridization and chemiluminescent nucleic acid testing. Acta Cytol 2005;49(2):120-6.

Qureshi MN, Rudelli RD, Tubbs RR, Biscotti CV, Layfield LJ: Role of HPV DNA testing in predicting cervical intraepithelial lesions: Comparison of HC HPV and ISH HPV. Diagn Cytopathol 2003;29(3):149-155.

Rowe LR, Aldeen W, Bentz JS. Prevalence and typing of HPV DNA by hybrid capture II in women with ASCUS, ASC-H, LSIL, and AGC on ThinPrep Pap tests. Diagn Cytopathol 2004;30(6):426-32.

Sailors J, Gander R, Saboorian MH, Berkley P, Foster B, Ashfaq R: Stability of PreservCyt for Hybrid Capture (HC II) HPV test. Diagn Cytopathol 2005;32(5):260-3.

Sarode VR, Werner C, Gander R, Foster B, Fulmer A, Saboorian MH, Ashfaq R: Reflex human papillomavirus DNA testing on residual liquid-based (TPPT) cervical samples. Cancer (Cancer Cytopathol) 2003;99(3):149-55.

Sherman ME, Schiffman M, Cox JT for the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) group: Effects of age and human papilloma viral load on colposcopy triage: Data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94(2):102-7.

Solomon D, Schiffman M, Tarone R, for the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) group: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93(4):293-299.

Solomon D, Schiffman M, Tarone R, for the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) group: Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397-402.

Stoler MH, Schiffman M, for the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) group: Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-1505.

Susumu N, Aoki D, Noda T, Nagashima Y, Hirao T, Tamada Y, Banno K, Suzuki A, Suzuki N, Tsuda H, Inazawa J, Nozawa S. Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers. Int J Gynecol Cancer 2005;15(1):70-80.

Tarkowski TA, Rajeevan MS, Lee DR, Unger ER: Improved detection of viral RNA isolated from liquid-based cytology samples. Mol Diagn 2001;6(2):125-30.

Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning G: Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou Tests using real-time polymerase chain reaction analysis. Cancer 2002; 94(8):2199-210.

Weaver EJ, Kovatich AJ, Bibbo M: Cyclin E expression and early cervical neoplasia in ThinPrep specimens. Acta Cytol 2000;44:301-4.

Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ for the ASCCP-sponsored Consensus Conference: 2001 consensus guidelines for the management of women with cervical cytologic abnormalities. JAMA 2002;287(16):2120-29.

Wright TC Jr, Lorincz A, Ferris DG, Richart RM, Ferenczy A, Mielzynska I, Borgatta L: Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998;178:962-6.

Xi LF, Toure P, Critchlow CW, Hawes SE, Dembele B, Sow PS, Kiviat NB: Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer 2003;103(6):803-809.

Yarkin F, Chauvin S, Konomi N, Wang W, Mo R, Bauchman G, Diaz A, Burstein D, Szporn A, Hauptman E, Zhang DY: Detection of HPV DNA in cervical specimens collected in cytologic solution by ligation-dependent PCR. Acta Cytol 2003;47(3):450-6.

Zhang W, Cohenford M, Lentrichia B, Isenberg HD, Simson E, Li H, Yi J, Zhang DY: Detection of chlamydia trachomatis by isothermal ramification amplification method: A feasibility study. J Clin Microbiol 2002; 40(1):128-132.

Zuna RE, Wang SS, Rosenthal DL, Jeronimo J, Schiffman M, Solomon D: Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS). Cancer (Cancer Cytopathol) 2005;105(5):253-62.

Zuna RE, Moore W, Dunn T: HPV DNA testing of the residual sample of liquid-based Pap test: Utility as a quality assurance monitor. Mod Pathol 2001;14(3):147-151.

ThinPrep Imaging System Studies
Biscotti C, Dawson A, Dziura B, Galup L, Darragh T, Rahemtulla A, Wills-Frank L: Assisted Primary Screening Using the Automated ThinPrep Imaging System. Am J Clin Pathol 2005;123(2):281-7.

Dawson AE. The Changing Face of Cervical Screening. Challenges for the Future. Diagn Cytopathol 2005;33(2):63-64.

Dawson A: Can we change the way we screen?: The ThinPrep Imaging System. Cancer (Cancer Cytopathol) 2004;102(6):340-4.

Dziura B, Quinn S, Richard K: Performance of an Imaging System vs. Manual Screening in the Detection of Squamous Intraepithelial Lesions of the Uterine Cervix. Acta Ctyol 2006;50(3):309-311.

Cost-Effectiveness Studies
Braly P, Sedlacek T, Kinney W, Sheets EE, Walton L, Farber F, Cox JT: Reporting the potential benefits of new technologies for cervical cancer screening. J Low Gen Tract Dis 2001;5(2):73-81.

Brown AD et al: Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA 1999;28(4):347-53.

Cochand-Priollet B, Cartier I, de Cremoux P, Le Gales C, Ziol M, Molinie V, Petitjean A, Dosda A, Merea E, Biaggi A, Gouget I, Arkwright S, Vacher-Lavenu MC, Vielh P, Coste J: Cost-effectiveness of liquid-based cytology with or without hybrid-capture II HPV test compared with conventional Pap smears: A study by the French society of clinical cytology. Diagn Cytopathol 2005;33(5):338-43.

Hutchinson ML et al: Clinical and cost implications of new technologies for cervical cancer screening: The impact of test sensitivity. Am J Manag Care 2000;6:766-780.

Llewellyn H: Re: An alternative cost-effectiveness analysis of ThinPrep in the Australian setting. Aust N Z J Obstet Gynaecol 2006;46(1):67.

Merea E, Le Gales C, Cochand-Priollet B, Cartier I, de Cremoux P, Vacher-Levenu MC, Vielh P, Coste J: Cost of screening for cancerous and precancerous lesions of the cervix. Diagn Cytopathol 2002;27(4):251-57.

Montz FJ, Farber FL, Bristow RE, Cornelison T: Impact of increasing Papanicolaou test sensitivity and compliance: A modeled cost and outcomes analysis. Obstet Gynecol 2001;97:781-8.

Neville AM, Quinn MA: An alternative cost effectiveness analysis of ThinPrep in the Australian setting. Aust N Z J Obstet Gynaecol 2005;45(4):289-94.

Sedlacek T et al: Cervical cancer screening: What is cost effectiveness? J Low Gen Tract Dis 1999;3:S1-S7.

Other Studies
Adams K, Absher K, Brill Y, Witzke D, Davey D: Reproducibility of subclassification of squamous intraepithelial lesions: conventional versus ThinPrep paps. J Low Gen Tract Dis 2003;7(3):203-8.

Alves VA, Bibbo M, Schmitt FC, Milanezi F, Longatto Filho A: Comparison of manual and automatedmethods of liquid-based cytology. A morphologic study. Acta Cytol 2004;48(2):187-93.

Baer A, Kiviat NB, Kulasingam S, Mao C, Kuypers J, Koutsky L: Liquid-based Papanicolaou smears without a transformation zone component: Should clinicians worry? Obstet Gynecol 2002;99(6):1053-9.

Banville N, Murray M, Turner L, Magee D, Gibbons D: The number of dyskaryotic cells on an initial ThinPrep cervical sample showing mild dyskaryosis has predictive value. Cytopathology 2005;16(3):120-4.

Bentz JS, Rowe LR, Gopez EV, Marshall CJ: The unsatisfactory ThinPrep Pap Test: Missed opportunity for disease detection? Am J Clin Pathol 2002;117:457-63.

Brogi E, Tambouret R, Bell DA: Classification of benign endometrial glandular cells in cervical smears from postmenopausal women. Cancer (Cancer Cytopathol) 2002;96(2):60-6.

Budge M, Halford J, Haran M, Mein J, Wright G: Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology. Aust N Z J Obstet Gynaecol 2005;45(3):215-9.

Chacho MS, Mattie ME, Schwartz PE: Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: A comparison. Cancer (Cancer Cytopathol) 2003;99(3):135-40.

Chang BS, Pinkus GS, Cibas ES: Exfoliated Endometrial Cell Clusters in Cervical Cytologic Preparations Are Derived from Endometrial Stroma and Glands. Am J Clin Pathol 2006;125:77-81.

Dalton P, MacDonald S, Boerner S: Acetic acid recovery of gynecologic liquid-based samples of apparent low squamous cellularity. Acta Cytol 2006;50(2):136-40.

Dowie R, Stoykova B, Crawford D, Desai M, Mather J, Morgan K, Shirt M: Liquid-based cytology can improve efficiency of cervical smear readers: evidence from timing surveys in two NHS cytology laboratories. Cytopathology 2006;17(2):65-72.

Eltabbakh GH et al: Significance of atypical glandular cells of undetermined significance of ThinPrep Papanicolaou smears. Gynecol Oncol 2000;78(2):245-250.

Eltabbakh GH et al: Significance of atypical squamous cells of undetermined significance of ThinPrep Papanicolaou smears. Gynecol Oncol 2000;79(1):44-49.

Haack LA, O'brien D, Selvaggi SM: Protocol for the processing of bloody cervical specimens: Glacial acetic acid and the ThinPrep(R) Pap Test. Diagn Cytopathol 2006;34(3):210-213 [Epub ahead of print]

Halford JA: Cytological features of chronic follicular cervicitis in liquid-based specimens: A diagnostic pitfall. Cytopathology 2002;13:364-70.

Hecht JL, Sheets EE, Lee KR: Atypical glandular cells of undetermined significance in conventional cervical/vaginal smears and thin-layer preparations. Cancer (Cancer Cytopathol) 2002;96(1):1-4.

Henderson S, Stevens M, Walker T. Rapid review of liquid-based smears as a quality control measure. Diagn Cytopathol 2004 Sep;31(3):141-6.

Hoerl HD, Roth-Cline MD, Shalkham JE, Pfister J, Stewart J 3rd, Guo Z, De Las Casas LE, Caya JG, Kurtycz DF: Rare atypical cells of undetermined significance (ASCUS): A clinically significant diagnosis? Diagn Cytopathol 2002;27(1):5-9.

Hoerl HD et al: Screening parameters for ThinPrep and conventional gynecologic cytology via automated monitoring. Acta Cytol 2000;44:618-624.

Kapanis K, Kiziridou A, Liberis V, Destouni C, Galazios: E-cadherin expression during progression of squamous intraepithelial lesions of the uterine cervix. Eur J Gynaecol Oncol 2005;26(6):608-10.

Kyroudi A, Papaefthimiou M, Symiakaki H, Mentzelopoulou P, Voulgaris Z, Karakitsos P: Increasing Diagnostic Accuracy with a cell Block Preparation from ThinLayer Endometrial Cytology. Acta Cytol 2006;50(1):63-9.

Lerud K, Osuala K: Cytologic Manifestation of Suture Granuloma in Exfoliative Vaginal ThinPrep Sample. Diag Cytopathol 2006; 34(4):289-90.

Maksem JA, Dhanwada V, Trueblood JE, Weidmann J, Kane B, Bolick DR, Bedrossian CW, Kurtycz DF, Stewart J 3rd: Testing Automated Liquid-Based Cytology Samples With a Manual Liquid-Based Cytology Method Using Residual Cell Suspensions From 500 ThinPrep Cases. Diag Cytopathpol 2006;34(6):391-6.

Morrison C, Prokorym P, Piquero C, Wakely PE, Nuovo GJ: Oral contraceptive pills are associated with artifacts in ThinPrep Pap smears that mimic low-grade squamous intraepithelial lesions. Cancer (Cancer Cytopathol) 2003;99(2):75-82.

Negri G, Menia E, Egarter-Vigl E, Vittadello F, Mian C: ThinPrep versus conventional Papanicolaou smear in the cytologic follow-up of women with equivocal cervical smears. Cancer (Cancer Cytopathol) 2003;99(6):342-5.

Ozkan F, Ramzy I, Mody DR. Glandular lesions of the cervix on thin-layer Pap tests. Validity of cytologic criteria used in identifying significant lesions. Acta Cytol 2004;48(3):372-9.

Quddus MR, Sung CJ, Eklund MJ, Zhang C, Steinhoff MM. Atypical squamous cells, cannot exclude HSIL: a review of original vs. duplicate thin-layer slides. J Reprod Med 2004;49(6):457-62.

Quddus MR, Sung CJ, Steinhoff MM, Lauchlan SC, Singer DB, Hutchinson ML: Atypical squamous metaplastic cells: Reproducibility, outcome, and diagnostic features on ThinPrep Pap Test. Cancer (Cancer Cytopathol) 2001;93:16-22.

Raab SS, Grzybicki DM, Hart AR, Kiely S, Andrew-Jaja C, Scioscia E: Willingness to pay for new Papanicolaou test technologies. Am J Clin Pathol 2002;117:524-533.

Rahimpanah F, Reid RI: Fallopian tube carcinoma detected by ThinPrep cytology smear. Med J Aust 2000;17(1):38.

Renshaw AA, Mody DR, Styer P, Schwartz M, Ducatman B, Colgan TJ: Papanicolaou tests with mixed high-grade and low-grade squamous intraepithelial lesion features: distinct performance in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytopathology. Arch Pathol Lab Med 2006;130(4):456-9.

Renshaw AA, Mody DR, Wang E, Haja J, Colgan T: Hyperchromatic Crowded Groups in Cervical Cytology - Differing Appearances and Interpretations in Conventional and ThinPrep Preparations. Arch Pathol Lab Med 2006;130:332-6.

Rowe LR, Bentz RS: A simple method to determine the need for glacial acetic acid treatment of bloody ThinPrep Pap test before slide processing. Diagn Cytopathol 2004;31(5):321-5.

Selvaggi SM: Background features of endometrial carcinoma on ThinPrep cytology. Diagn Cytopathol 2005;33(3):162-5.

Slater DN, Rice S, Stewart R, Melling SE, Hewer EM, Smith JH: Proposed Sheffield quantitative criteria in cervical cytology to assist the grading of squamous cell dyskaryosis, as the British Society for Clinical Cytology definitions require amendment. Cytopathology 2005;16(4):179-92.

Snyder T, Renshaw A, Styler P, Mody D, Colgan T: Altered Recognition of Reparative Changes in thinPrep Specimens in the College of American Pathologists Gynecologic Cytology Programs. Arch Pathol Lab Med 2005;129(7):861-5.

Sweeney BJ, Haq Z, Happel JF, Weinstein B, Schneider D: Comparison of the effectiveness of two liquid-based Papanicolaou systems in the handling of adverse limiting factors, such as excessive blood. Cancer (Cancer Cytopathol) 2006;108(1):27-31.